[1]
|
Simultaneous determination of emtricitabine, tenofovir alafenamide fumarate and dolutegravir sodium by validated stability-indicating RP-HPLC-DAD method
Annales Pharmaceutiques Françaises,
2023
DOI:10.1016/j.pharma.2022.08.006
|
|
|
[2]
|
Utilization of Chemometric-Aided UV Spectrophotometric Methods for Concurrent Assessment of Emtricitabine, Tenofovir Disoproxil Fumarate, Elvitegravir, and Cobicistat in Tablet Formulation
Journal of AOAC International,
2023
DOI:10.1093/jaoacint/qsad067
|
|
|
[3]
|
Utilization of Chemometric-Aided UV Spectrophotometric Methods for Concurrent Assessment of Emtricitabine, Tenofovir Disoproxil Fumarate, Elvitegravir, and Cobicistat in Tablet Formulation
Journal of AOAC International,
2023
DOI:10.1093/jaoacint/qsad067
|
|
|
[4]
|
Simultaneous determination of emtricitabine, tenofovir alafenamide fumarate and dolutegravir sodium by validated stability-indicating RP-HPLC-DAD method
Annales Pharmaceutiques Françaises,
2022
DOI:10.1016/j.pharma.2022.08.006
|
|
|
[5]
|
p-Sulfonatocalixarene versus p-thiasulfonatocalixarene: encapsulation of tenofovir disoproxil fumarate and implications to ESI-MS, HPLC, NMR, DFT and anti-MRSA activities
Journal of Inclusion Phenomena and Macrocyclic Chemistry,
2021
DOI:10.1007/s10847-020-01022-w
|
|
|
[6]
|
Quantitative Analysis of Emtricitabine in Dosage Forms Using Green RP-HPTLC and Routine NP-HPTLC Methods—A Contrast of Validation Parameters
ACS Omega,
2020
DOI:10.1021/acsomega.0c05537
|
|
|
[7]
|
Profiles of Drug Substances, Excipients, and Related Methodology
Profiles of Drug Substances, Excipients and Related Methodology,
2020
DOI:10.1016/bs.podrm.2019.10.003
|
|
|
[8]
|
Quantitative Analysis of Emtricitabine in Dosage Forms Using Green RP-HPTLC and Routine NP-HPTLC Methods—A Contrast of Validation Parameters
ACS Omega,
2020
DOI:10.1021/acsomega.0c05537
|
|
|
[9]
|
Profiles of Drug Substances, Excipients, and Related Methodology
Profiles of Drug Substances, Excipients and Related Methodology,
2020
DOI:10.1016/bs.podrm.2019.10.003
|
|
|
[10]
|
Profiles of Drug Substances, Excipients, and Related Methodology
Profiles of Drug Substances, Excipients and Related Methodology,
2020
DOI:10.1016/bs.podrm.2019.10.003
|
|
|
[11]
|
A Novel Stability Indicating RP-HPLC Method Development and Validation for Simultaneous
Estimation of Bictegravir, Emtricitabine and Tenofovir in Pure and Fixed Dose Combination
Asian Journal of Organic & Medicinal Chemistry,
2019
DOI:10.14233/ajomc.2019.AJOMC-P163
|
|
|
[12]
|
Simultaneous Estimation and Validation of Tenofovir Disoproxil Fumarate, Emtricitabine and Efavirenz by RP-HPLC Method in Combined tablet Dosage Form
Current Pharmaceutical Analysis,
2019
DOI:10.2174/1573412914666180208152021
|
|
|